Clover Health Investments (CLOV)
(Real Time Quote from BATS)
$3.08 USD
-0.04 (-1.28%)
Updated Sep 17, 2025 11:04 AM ET
2-Buy of 5 2
C Value D Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CLOV 3.08 -0.04(-1.28%)
Will CLOV be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CLOV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLOV
Here's Why You Should Add CLOV Stock to Your Portfolio Now
Bears are Losing Control Over Clover Health Investments (CLOV), Here's Why It's a 'Buy' Now
CLOV: What are Zacks experts saying now?
Zacks Private Portfolio Services
CLOV Q2 Earnings In Line, Stock Falls on Raised Insurance BER View
Clover Health Investments, Corp. (CLOV) Q2 Earnings Meet Estimates
Clover Health Pre-Q2 Earnings Analysis: Buy, Sell or Hold the Stock?
Other News for CLOV
CLOV forms NR7 on September 16
Clover Health (CLOV) Boosts Efficiency with Availity Partnership
Clover Health launches Availity Essentials portal
Clover Health launches Availity Essentials portal
Is CLOV building bullish momentum? Upper Bollinger Band Walk shows up after rising 2.61%